![](/img/cover-not-exists.png)
U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
Axelson, M., Liu, K., Jiang, X., He, K., Wang, J., Zhao, H., Kufrin, D., Palmby, T., Dong, Z., Russell, A. M., Miksinski, S., Keegan, P., Pazdur, R.Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-12-1956
Date:
May, 2013
File:
PDF, 195 KB
english, 2013